HSV
Once-Daily Regimen of Valaciclovir Is Well Tolerated, Effective
Published in Proteomics Weekly, November 2nd, 1998
Genital herpes simplex virus (HSV) infection affects millions of people worldwide and causes significant morbidity, especially in sexually active young adults (Nahmias et al., Scand J Infect Dis Suppl, 1990;69:19-36; Johnson et al., N Engl J Med, 1989;321:7-12; and others).
M. Reitano, Reitano and Stern Research, New York, and colleagues performed a randomized, double-blind study of valaciclovir for the suppression of recurrent genital herpes among 1,479 immunocompetent patients ("Valaciclovir for the Suppression of Recurrent Genital...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (1998-11-02)
More Articles from Proteomics Weekly
- CMV
Serum-Inducible Kinases Have Key Role in Cell-Mediated IE Protein Phosphorylation - EBV
Cell Block Preparation Preserves Details of Cellular RNA - HSV
Activity of Virus Entry Mediator Depends on the Form of gD Expressed - HSV-1
Model of the Surface of DNA Is Presented - HSV-1
Nerve Growth Factor-Inducible Cellular Activity is Characterized - Suicide Gene Therapy
Nonhuman Primate Study Suggests Intracerebral Suicide Gene Therapy Feasible - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
